PMA P030052S026

Device
UroVysion Bladder Cancer Kit
Applicant
Abbott Molecular
PMA number
P030052
Supplement
S026
Product code
NAH
Decision date
2019-08-26
Classification
System, Test, Tumor Marker, For Detection Of Bladder Cancer
Generic name
System, test, tumor marker, for detection of bladder cancer
Approval order statement
Update to software.

Current openFDA PMA Record#

Device
UroVysion Bladder Cancer Kit
Applicant
Abbott Molecular
PMA number
P030052
Supplement
S026
Product code
NAH
Generic name
System, test, tumor marker, for detection of bladder cancer
Decision date
2019-08-26
Decision code
OK30
Date received
2019-07-31
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Update to software.